Cargando…

Hospital admissions for severe infections in people with chronic kidney disease in relation to renal disease severity and diabetes status

BACKGROUND: Immunosuppressive agents are being investigated for the treatment of chronic kidney disease (CKD) but may increase risk of infection. This was a retrospective observational study intended to evaluate the risk of hospitalized infection in patients with CKD, by estimated glomerular filtrat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berni, Ellen, Pritchard, Nicholas, Jenkins‐Jones, Sara, Ambery, Philip, Jain, Meena, Jermutus, Lutz, Scott, Laura A., Currie, Craig J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354815/ https://www.ncbi.nlm.nih.gov/pubmed/30815560 http://dx.doi.org/10.1002/edm2.29

Ejemplares similares

Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status
por: Currie, Craig J., et al.
Publicado: (2019)

Glucagon and exenatide improve contractile recovery following ischaemia/reperfusion in the isolated perfused rat heart
por: Lindsay, Ross T., et al.
Publicado: (2023)

Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study
por: Nahra, Rajaa, et al.
Publicado: (2021)

Severe periodontitis associated with chronic kidney disease
por: Jain, Anurag, et al.
Publicado: (2013)

Apelin-36-[L28A] and Apelin-36-[L28C(30kDa-PEG)] peptides that improve diet induced obesity are G protein biased ligands at the apelin receptor
por: Nyimanu, Duuamene, et al.
Publicado: (2019)

Efficacy and safety of cotadutide, a dual glucagon‐like peptide‐1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease
por: Parker, Victoria E. R., et al.
Publicado: (2022)

Disease severity and renal outcomes of patients with chronic kidney disease infected with COVID-19
por: Gur, Efrat, et al.
Publicado: (2022)

Diagnostic performance of renal ultrasonography in detecting chronic kidney disease of various severity
por: Kodikara, Iroshani, et al.
Publicado: (2020)

Glycated hemoglobin level on admission associated with progression to severe disease in hospitalized patients with non‐severe coronavirus disease 2019
por: Numaguchi, Ryutaro, et al.
Publicado: (2022)

Machine learning prediction for COVID-19 disease severity at hospital admission
por: Raman, Ganesh, et al.
Publicado: (2023)

Hyperglicemia at the Admission as Predictor of Severity
por: Hernandez Valdez, Astrid Paola, et al.
Publicado: (2021)

Development and validation of an LC-MS/MS method for detection and quantification of in vivo derived metabolites of [Pyr(1)]apelin-13 in humans
por: Nyimanu, Duuamene, et al.
Publicado: (2019)

Utility of warning signs in guiding admission and predicting severe disease in adult dengue
por: Leo, Yee-Sin, et al.
Publicado: (2013)

Elevated serum concentrations of HE4 as a novel biomarker of disease severity and renal fibrosis in kidney disease
por: Wan, Jianxin, et al.
Publicado: (2016)

Comprehensive Care for People With Diabetic Kidney Disease
por: Jain, Koyal, et al.
Publicado: (2015)

Renal arterial resistive index is associated with severe histological changes and poor renal outcome during chronic kidney disease
por: Bigé, Naïke, et al.
Publicado: (2012)

Renal denervation using carbon dioxide renal angiography in patients with uncontrolled hypertension and moderate to severe chronic kidney disease
por: Hameed, Mohammed Awais, et al.
Publicado: (2017)

Cognitive impairment in patients with moderate to severe chronic kidney disease: the Salford kidney cohort study
por: Tollitt, James, et al.
Publicado: (2020)

Non-Response to Antibiotic Treatment in Adolescents for Four Common Infections in UK Primary Care 1991–2012: A Retrospective, Longitudinal Study
por: Berni, Ellen, et al.
Publicado: (2016)

Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study
por: Berni, Ellen, et al.
Publicado: (2017)

The Model for End-Stage Liver Disease-Sodium Score at Admission Is Prognostic of Covid-19 Disease Severity
por: Wagner, Jason, et al.
Publicado: (2020)

Admission Hyperglycemia in Non-diabetics Predicts Mortality and Disease Severity in COVID-19: a Pooled Analysis and Meta-summary of Literature
por: Sachdeva, Sonali, et al.
Publicado: (2020)

Cortisol and dehydroepiandrosterone sulphate levels in ICU patients upon admission correlate with severity of disease
por: Dimopoulou, I, et al.
Publicado: (2006)

PENTRAXIN 3 LEVELS CORRELATE WELL WITH DISEASE SEVERITY AT ADMISSION IN COVID-19 PATIENTS
por: Işık, Mehmet Emirhan, et al.
Publicado: (2022)

Renal Function and Risk Factors of Moderate to Severe Chronic Kidney Disease in Golestan Province, Northeast of Iran
por: Najafi, Iraj, et al.
Publicado: (2010)

High dependency renal unit for the management of COVID-19 in patients with severe acute or chronic kidney disease
por: Thakare, Sayali, et al.
Publicado: (2022)

Chest CT severity score and radiological patterns as predictors of disease severity, ICU admission, and viral positivity in COVID-19 patients
por: Bellos, Ioannis, et al.
Publicado: (2021)

Palliative care for children and young people with stage 5 chronic kidney disease
por: Craig, Finella, et al.
Publicado: (2021)

Severe agitation in severe early-onset Alzheimer’s disease resolves with ECT
por: Aksay, Suna Su, et al.
Publicado: (2014)

The severity of acute kidney injury predicts progression to chronic kidney disease
por: Chawla, Lakhmir S, et al.
Publicado: (2011)

The Model of Mortality with Incident Cirrhosis (MoMIC) and the model of Long-term Outlook of Mortality in Cirrhosis (LOMiC)
por: Berni, Ellen R, et al.
Publicado: (2019)

Denosumab-Induced Severe Hypocalcaemia in Chronic Kidney Disease
por: Jalleh, Ryan, et al.
Publicado: (2018)

Prevalence and incidence of kidney diseases leading to hospital admission in people living with HIV in France: an observational nationwide study
por: Louis, Magali, et al.
Publicado: (2019)

Mixed connective tissue disease and severe renal disease – an apparent misconception?
por: Pinheiro, Filipe Oliveira, et al.
Publicado: (2022)

Chronic Kidney Disease: Role of Diet for a Reduction in the Severity of the Disease
por: Naber, Tania, et al.
Publicado: (2021)

Previous hospital admissions and disease severity predict the use of antipsychotic combination treatment in patients with schizophrenia
por: Bolstad, Albert, et al.
Publicado: (2011)

Platelet Count in Patients with Mild Disease at Admission is Associated with Progression to Severe Hantavirus Cardiopulmonary Syndrome
por: López, René, et al.
Publicado: (2019)

Early and late mortality following unscheduled admissions for severe liver disease across England and Wales
por: Roberts, Stephen E., et al.
Publicado: (2019)

Impact of pre-admission antithrombotic therapy on disease severity and mortality in patients hospitalized for COVID-19
por: Corrochano, Mariana, et al.
Publicado: (2021)

Fatty liver on computed tomography scan on admission is a risk factor for severe coronavirus disease
por: Okuhama, Ayako, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t01npb1uia8s1cit3cgiu2nl8m